Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts

L.H. van der Helm; N.J.G.M. Veeger; M. van Marwijk Kooy; A. Beeker; O. de Weerdt; M. de Groot; C. Alhan; M. Hoogendoorn; L. Laterveer; A.A. van de Loosdrecht; J. Koedam; E. Vellenga; G. Huls

doi:https://doi.org/10.1016/j.leukres.2013.03.022

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts

L.H. van der Helm, N.J.G.M. Veeger, M. van Marwijk Kooy, A. Beeker, O. de Weerdt, M. de Groot, C. Alhan, M. Hoogendoorn, L. Laterveer, A.A. van de Loosdrecht, J. Koedam, E. Vellenga, G. Huls

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	877-882
Journal	Leukemia research
Volume	37
Issue number	8
DOIs	https://doi.org/10.1016/j.leukres.2013.03.022
Publication status	Published - 2013

Access to Document

https://doi.org/10.1016/j.leukres.2013.03.022

Cite this

van der Helm, L. H., Veeger, N. J. G. M., van Marwijk Kooy, M., Beeker, A., de Weerdt, O., de Groot, M., Alhan, C., Hoogendoorn, M., Laterveer, L., van de Loosdrecht, A. A., Koedam, J., Vellenga, E., & Huls, G. (2013). Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts. Leukemia research, 37(8), 877-882. https://doi.org/10.1016/j.leukres.2013.03.022

@article{591c365f422647988894c2501043fe0f,

title = "Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts",

author = "{van der Helm}, L.H. and N.J.G.M. Veeger and {van Marwijk Kooy}, M. and A. Beeker and {de Weerdt}, O. and {de Groot}, M. and C. Alhan and M. Hoogendoorn and L. Laterveer and {van de Loosdrecht}, A.A. and J. Koedam and E. Vellenga and G. Huls",

year = "2013",

doi = "https://doi.org/10.1016/j.leukres.2013.03.022",

language = "Undefined/Unknown",

volume = "37",

pages = "877--882",

journal = "Leukemia research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "8",

}

van der Helm, LH, Veeger, NJGM, van Marwijk Kooy, M, Beeker, A, de Weerdt, O, de Groot, M, Alhan, C, Hoogendoorn, M, Laterveer, L, van de Loosdrecht, AA, Koedam, J, Vellenga, E & Huls, G 2013, 'Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts', Leukemia research, vol. 37, no. 8, pp. 877-882. https://doi.org/10.1016/j.leukres.2013.03.022

TY - JOUR

T1 - Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts

AU - van der Helm, L.H.

AU - Veeger, N.J.G.M.

AU - van Marwijk Kooy, M.

AU - Beeker, A.

AU - de Weerdt, O.

AU - de Groot, M.

AU - Alhan, C.

AU - Hoogendoorn, M.

AU - Laterveer, L.

AU - van de Loosdrecht, A.A.

AU - Koedam, J.

AU - Vellenga, E.

AU - Huls, G.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1016/j.leukres.2013.03.022

DO - https://doi.org/10.1016/j.leukres.2013.03.022

M3 - Article

C2 - 23628552

SN - 0145-2126

VL - 37

SP - 877

EP - 882

JO - Leukemia research

JF - Leukemia research

IS - 8

ER -